China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Multicenter Study on the Impact of Rapid Diagnostic Tests (RDTs) on Treatment Patterns and Clinical Outcomes in Patients with Carbapenem-Resistant Organism (CRO) Infections'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132207
Registration Time: 2026/09/10
Type: Interventional study
Primary Sponsor: Huashan Hospital, Fudan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342804
Published by HT Digital Content Services with permission from Health Daily Digest....